{"doi":"10.1093/crocol/otaa013","title":"A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease","abstract":"BACKGROUND: Ustekinumab was approved for moderate and severe Crohn's disease (CD) in 2016, but little is known about long-term outcomes. METHODS: A retrospective study evaluated all patients with CD treated with ustekinumab, including patients with reinduction. C-reactive protein (CRP), Harvey-Bradshaw Index (HBI), Short Inflammatory Bowel Disease (SIBDQ), and endoscopy outcomes were collected prospectively. RESULTS: Ninety-six patients received ustekinumab, resulting in improvement in CRP, HBI, and SIBDQ scores with 68% endoscopic improvement/remission. Thirty-four patients underwent reinduction, resulting in improved HBI and CRP. CONCLUSIONS: Ustekinumab in refractory CD results in significant clinical and endoscopic improvement and reinduction may be a viable option to recapture response.","journal":"Crohn s & Colitis 360","year":2020,"id":70291,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":19,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.8384,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":372977,"name":"Lauren E. Carlini","orcid":null,"position":1,"is_corresponding":false},{"id":372978,"name":"Caroline Duley","orcid":null,"position":2,"is_corresponding":false},{"id":372979,"name":"Ailish Garrett","orcid":null,"position":3,"is_corresponding":false},{"id":372980,"name":"Kim Annis","orcid":null,"position":4,"is_corresponding":false},{"id":372981,"name":"Julianne Wagnon","orcid":null,"position":5,"is_corresponding":false},{"id":372982,"name":"Robin Dalal","orcid":null,"position":6,"is_corresponding":false},{"id":333736,"name":"Elizabeth Scoville","orcid":"0000-0001-5326-2221","position":7,"is_corresponding":false},{"id":372983,"name":"Dawn B. Beaulieu","orcid":null,"position":8,"is_corresponding":false},{"id":350754,"name":"David A. Schwartz","orcid":"0000-0002-7486-8545","position":9,"is_corresponding":false},{"id":372984,"name":"Sara N. Horst","orcid":null,"position":10,"is_corresponding":false},{"id":371874,"name":"Audrey Bennett","orcid":"0000-0001-8555-5723","position":0,"is_corresponding":true}],"reference_count":18,"raw_metadata":null,"created_at":"2026-07-18T21:43:11.119231Z","pmid":"32201860","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}